Email Updates

Search form

You are here

Webinar & Meeting Reports

  • April 2, 2019
    Results from the ECHO study is expected in mid-2019 and will help guide the implementation of safe, effective policies and services that will enable women at high risk of HIV to make fully informed choices about contraception and HIV prevention. Join us on April 2 at 9am ET to learn more.
  • March 4, 2019 to March 7, 2019

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) will take place March 4-7 in Seattle, Washington. Read on to review the coverage, access webcasts of conference sessions and to check out what caught AVAC’s attention.

  • February 26, 2019

    On Tuesday, February 26, The Population Council, IRMA and AVAC presented a webinar to learn how user choice and control inform the Council’s MPT product development strategy.


    • Tom Zydowsky, PhD; Senior Scientist, Director of Biomedical Research & Pharmaceutical Development, Center for Biomedical Research
    • Barbara Friedland, MPH; Associate II, Clinical Project Manager, Center for Biomedical Research
  • February 20, 2019

    On February 20, 2019, the OPTIONS Consortium presented a webinar on the PrEP Communications Accelerator—an interactive tool that assists in the development of a demand creation campaign strategy to promote PrEP uptake among target audiences in sub-Saharan Africa. This webinar covered:

    • The role of demand creation strategies to drive PrEP uptake
  • January 23, 2019

    Back by popular demand! As tuberculosis (TB) is the leading global killer of people living with HIV, TB programming must be prioritized and integrated within life-saving bilateral efforts such as PEPFAR. The expected release of the PEPFAR Country Operational Plans (COPs) provides a critical opportunity for advocates to ensure that the latest developments in TB treatment, prevention and diagnostics are implemented within PEPFAR countries.

  • November 27, 2018

    On Tuesday, 27 November 2018, 8-10am EST (3-5pm SAST) there was a webinar that provided an update on an exciting human-centred design project focused on better understanding and designing HIV prevention programs for adolescent girls and young women in South Africa.

  • October 28, 2018 to October 31, 2018

    The program is of interest to clinical investigators from across the globe to review current research and to discuss its implications for HIV management strategies. In addition to looking at these treatment issues, the Congress is moving into areas, such as prevention, with time in the program focused on PrEP and issues across Europe and beyond.

  • October 21, 2018 to October 25, 2018

    Whether you attended the conference in Madrid or followed the action from afar, AVAC kept you connected! Read on for information on AVAC sessions, a sortable roadmap, the Advocates’ Corner and more!

  • October 1, 2018

    On Monday, October 1st, IRMA and AVAC led a lively discussion on the BRAND NEW IRMA report titled: Whose Choice is it Anyway? Analysis of Comments to and Responses from NIH’s 2017 “Refining the Research Enterprise” Request for Input on Research Priorities. (How’s that for the longest report title in the world?)

  • September 17, 2018

    On Thursday, September 17, IRMA and AVAC hosted this global teleconference which discussed rectal microbicide studies underway and being planned that incorporate common anal sex practices, focusing on the development of gels, douches, fast-dissolving rectal tablets (inserts) and suppositories – options that recognize the complexity of sex, human nature, pleasure and HIV.

    Presenters included Jose Bauermeister (University of Pennsylvania), Kenneth Ho (University of Pittsburgh) and Craig Hendrix (Johns Hopkins). IRMA’s Jim Picket will moderated the call.